BIO-Europe® 2012 welcomes global life science companies to Hamburg and Schleswig-Holstein region
EBD Group, the leading partnering firm for the life science industry, will hold the 18th annual BIO-Europe® international partnering conference in Hamburg, Germany November 12–14, 2012 at the CCH Congress Center Hamburg. BIO-Europe is collaborating with ScanBalt™ fmba to welcome big pharma and biotech leaders to the ScanBalt BioRegion comprised of the Nordic and Baltic countries, Poland, Northern Germany, Northwestern Russia and Northern Netherlands.
“ScanBalt is pleased to bring this international biotech partnering event to the ScanBalt BioRegion ,” said Peter Frank, General Secretary of ScanBalt. “As a globally competitive cluster, our BioRegion is dedicated to innovation in clinical research, healthcare and bio-medical and medical expertise. ScanBalt members have a lot to offer. I encourage members to register soon and receive a discount of EUR 200 off the prevailing registration rate.”
As Europe’s largest partnering conference serving the global biotechnology industry, BIO-Europe® attracts the world’s top dealmakers from biotech, pharma and finance along with exciting emerging companies.
“BIO-Europe is our premier European partnering event, and this year it will focus on opportunities for Nordic and North German companies to expand into global relationships.,” said Carola Schropp, President of EBD Group. “The possibilities for collaboration are unlimited.”
This year’s opening plenary features industry staple Chris Morrison of Elsevier Business Intelligence as moderator for “New Investment Models for Early Stage Development.” Speakers on the plenary include Hubert Birner of TVM Life Science Management GmbH, and Gilles Nobecourt of Edmond de Rothschild Investment Partners, both of whom have started new funds dedicated to the life science sector this year.
The event is also being held in collaboration with Norgenta, the service agency of Hamburg and the Federal State of Schleswig-Holstein, established to support life science activities in Northern Germany. “Life Science Nord” is the umbrella brand, under which the agency connects life science activities for different stakeholder groups to set up an internationally competitive cluster.
Partnering at BIO-Europe® 2012 is powered by partneringONE®, the leading conference networking solution for the life sciences. With partneringONE you can create a partnering profile and begin efficiently identifying and requesting meetings with potential collaborators. For more information go to: http://www.ebdgroup.com/bioeurope/partnering/index.php
The 2011 event boasted 14,765 scheduled one-to-one meetings with 3,565 licensing opportunities posted from among 1,596 companies that attended. Partnering remains the core drug development strategy of big pharma and biotech in the current economy.